Since she took the top job at AusBiotech on the eve of the BIO conference earlier this year, Anna Lavelle has done a lot of listening. Now she's ready to talk -- about her role and her vision for the organisation.

Australia's Therapeutic Goods Administration (TGA) has approved a clinical trial of a new immunotherapeutic vaccine for chronic hepatitis C infection, developed by VacTX, a joint venture between EqiTX (ASX:EQX) and the CRC for Vaccine Technology

Psiron (ASX:PSX) has presented a research paper at the International Meeting on Molecular Biology of Picornaviruses showing anticancer activity of a new strain of its lead product (CVA21) against a wider range of colorectal cancer cells.

Australian Red Cross Blood Service (ARCBS) executive Dr Anna Lavelle has been appointed as the new head of Australia's peak biotechnology industry organisation, AusBiotech.